T1	Concept 31 39	COVID-19
T2	Concept 40 48	patients
T3	Concept 59 67	elevated
T4	Concept 68 75	cardiac
T5	Concept 76 82	marker
T6	Concept 83 89	levels
T7	Concept 5 9	half
R1	in-context Arg1:T2 Arg2:T1	
R2	has-property Arg1:T2 Arg2:T7	
R3	has-property Arg1:T2 Arg2:T6	
R4	has-property Arg1:T6 Arg2:T3	
R5	in-context Arg1:T6 Arg2:T5	
R6	in-context Arg1:T5 Arg2:T4	
T8	Concept 109 118	diagnosis
T9	Concept 119 124	value
T10	Concept 128 135	Ab test
T11	Concept 137 146	our study
T12	Action 147 155	revealed
T13	Concept 158 164	strong
T14	Concept 165 173	positive
T15	Concept 174 185	correlation
T16	Concept 231 263	since 2-week after illness onset
T17	Concept 203 211	severity
T18	Concept 216 230	antibody titer
T20	Concept 273 283	first time
T22	Concept 287 295	COVID-19
T23	Concept 296 304	patients
R7	in-context Arg1:T9 Arg2:T8	
R8	in-context Arg1:T9 Arg2:T10	
R9	subject Arg1:T12 Arg2:T9	
R10	subject Arg1:T12 Arg2:T11	
R11	target Arg1:T12 Arg2:T15	
R12	has-property Arg1:T15 Arg2:T14	
R13	has-property Arg1:T15 Arg2:T13	
R14	in-time Arg1:T15 Arg2:T16	
R15	in-context Arg1:T15 Arg2:T18	
T24	Concept 194 202	clinical
R16	in-context Arg1:T17 Arg2:T24	
R17	in-context Arg1:T15 Arg2:T17	
R19	in-context Arg1:T17 Arg2:T23	
R18	in-context Arg1:T18 Arg2:T23	
R20	in-context Arg1:T23 Arg2:T22	
R21	in-time Arg1:T17 Arg2:T20	
R22	in-time Arg1:T18 Arg2:T20	
T25	Concept 342 360	COVID-19-confirmed
T26	Concept 361 369	patients
T27	Concept 338 341	116
T28	Concept 374 376	54
T29	Concept 377 382	years
R23	in-context Arg1:T26 Arg2:T25	
R24	in-context Arg1:T27 Arg2:T26	
R25	has-property Arg1:T26 Arg2:T28	
R26	in-context Arg1:T28 Arg2:T29	
T30	Concept 441 445	male
R27	has-property Arg1:T26 Arg2:T30	
T19	Concept 468 474	severe
T21	Concept 475 486	respiratory
T31	Concept 487 494	illness
T32	Concept 505 517	non-invasive
T33	Concept 521 531	mechanical
T34	Concept 532 543	ventilation
T35	Concept 454 463	our cases
T37	Action 464 467	had
R28	subject Arg1:T37 Arg2:T35	
R29	target Arg1:T37 Arg2:T31	
R30	in-context Arg1:T31 Arg2:T21	
R31	has-property Arg1:T31 Arg2:T19	
A1	Negated T37
R34	has-property Arg1:T34 Arg2:T33	
R35	has-property Arg1:T34 Arg2:T32	
T38	Concept 614 623	suspected
T39	Concept 624 628	case
T40	Action 634 641	require
A2	Negated T40
T41	Concept 642 650	enhanced
T42	Concept 651 655	care
R36	target Arg1:T40 Arg2:T42	
R37	subject Arg1:T40 Arg2:T39	
R38	has-property Arg1:T39 Arg2:T38	
R39	has-property Arg1:T42 Arg2:T41	
R40	target Arg1:T37 Arg2:T34	
R32	entails Arg1:T37 Arg2:T40	
T36	Concept 708 710	UK
R33	in-place Arg1:T40 Arg2:T36	
T43	Concept 754 762	severity
T44	Concept 766 774	COVID-19
T45	Concept 775 782	disease
R41	in-context Arg1:T45 Arg2:T44	
R42	in-context Arg1:T43 Arg2:T45	
T46	Action 786 796	associated
R43	subject Arg1:T46 Arg2:T43	
T47	Concept 812 815	age
T48	Concept 802 811	increased
R44	has-property Arg1:T47 Arg2:T48	
R45	target Arg1:T46 Arg2:T47	
T49	Concept 825 836	comorbidity
R46	is-a Arg1:T46 Arg2:T49	
T50	Concept 847 853	severe
T51	Concept 854 861	disease
T53	Concept 869 876	limited
A3	Negated T53
T52	Concept 891 897	groups
T54	Concept 886 890	risk
R47	has-property Arg1:T52 Arg2:T54	
R48	has-property Arg1:T51 Arg2:T53	
R49	in-context Arg1:T53 Arg2:T52	
R50	has-property Arg1:T51 Arg2:T50	
